Process analytical technology (PAT) for biopharmaceutical products

The “Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century—A Risk Based Approach” initiative announced by the FDA in August 2002 to improve and modernize pharmaceutical manufacturing facilitated adoption of process analytical technology (PAT) by the pharmaceutical industry...

Full description

Saved in:
Bibliographic Details
Published in:Analytical and bioanalytical chemistry 2010-09, Vol.398 (1), p.137-154
Main Authors: Rathore, A. S, Bhambure, R, Ghare, V
Format: Article
Language:English
Subjects:
Analytical Chemistry
Biochemistry
Biological products
bioprocessing
Biotechnology - methods
Biotechnology - standards
Characterization and Evaluation of Materials
Chemistry
Chemistry and Materials Science
Drug Industry - standards
Evolution
Food Science
Humans
Laboratory Medicine
Mathematical analysis
Monitoring/Environmental Analysis
Monitors
Optimization
PAT
Pharmaceuticals
Process analytical technology, PAT
Production processes
Quality assurance
Quality by design
Quality Control
Real time
Rest
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The “Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century—A Risk Based Approach” initiative announced by the FDA in August 2002 to improve and modernize pharmaceutical manufacturing facilitated adoption of process analytical technology (PAT) by the pharmaceutical industry. The potential for improved operational control and compliance resulting from continuous real-time quality assurance was highlighted as a likely benefit that would result from PAT implementation. A considerable amount of work has been done on this topic by academic and industrial contributors in the last decade. In this paper, we will start with a brief overview of evolution of PAT concepts and a review of their application in the wider pharmaceutical industry. The rest of the paper focuses on PAT applications for biotech processes with emphasis on developments in the last five years. It is our observation that while significant advances have been accomplished with regard to our ability to analyze/monitor key process and quality attributes in the biotech industry, much more needs to be done with regard to utilizing the collected data for subsequent control of the process, to achieve optimum yield and product quality. The latter is necessary to achieve the benefits that will result from PAT implementation. [graphic removed]
ISSN:1618-2642
1618-2650
DOI:10.1007/s00216-010-3781-x